BioGeneSys Inc.

BioGenesis has developed a sensor and measurement system for early diagnosis of Alzheimer disease using a small amount of blood. There is a very low concentration of Alzheimer markers in the blood due to the membrane separating the brain and blood vessels. To solve this problem, a sensor that is 10,000 times more accurate than the existing technology has been developed to precisely measure the dementia markers in the blood.

We develop a diagnostic kit that can detect Alzheimer disease before its symptoms appear and monitor its progress by simply and inexpensively testing dementia using blood.

It will be registered as a health checkup item in the future and will be a scaffolding technology that can overcome Alzheimer by periodically inspecting once or twice a year.

Company Information

Company Name: BioGeneSys Inc.
Foundation Date: Jun 25. 2018
CEO: Shim Joon Sub
Address: Chmbit-gwan Rm# 609, Kwangwoon-Ro 20, Nowon-gu, Seoul
Tel: 02-940-8671
E-Mail: shim@kw.ac.kr

3F Techno Complex Building, College of Science & Technology, Korea university
T.02-3290-5894~7 Copyright© 2017 KOREA UNIVERSITY HOLDINGS. ALL RIGHTS RESERVED